Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 3,565 | 3,316 | 2,660 | 2,359 | 684 |
Gross Profit | 3,565 | 3,316 | 2,660 | 2,359 | 684 |
Operating Expenses | 20,237 | 15,596 | 15,110 | 15,927 | 14,614 |
Operating Income | -16,672 | -12,280 | -12,450 | -13,567 | -13,930 |
Interest Expense | -446 | 0 | 0 | 0 | 0 |
Other Income | -23 | 328 | 142 | -101 | -1 |
Pre-tax Income | -16,249 | -11,952 | -12,308 | -13,668 | -13,931 |
Income Tax | N/A | -8,945 | -36 | -70 | N/A |
Net Income Continuous | -16,249 | -3,008 | -12,272 | -13,599 | -13,931 |
Net Income | $-16,249 | $-3,008 | $-12,272 | $-13,599 | $-13,931 |
EPS Basic Total Ops | -9.60 | -1.32 | -8.52 | -9.36 | -9.72 |
EPS Basic Continuous Ops | -9.64 | -1.37 | -8.48 | -9.41 | -9.68 |
EPS Diluted Total Ops | -9.60 | -1.32 | -8.52 | -9.36 | -9.72 |
EPS Diluted Continuous Ops | -9.64 | -1.37 | -8.48 | -9.41 | -9.68 |
EBITDA(a) | $-16,504 | $-12,763 | $-11,831 | $-13,516 | $-13,898 |